Mannell, H.;Hellwig, N.;Gloe, T.;Plank, C.;Sohn, H.Y.;Groesser, L.;Walzog, B.;Pohl, U.;Krotz, F.
Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo
J. Vasc. Res.
2008
45
2
153-163

Zhong, J.L.;Poghosyan, Z.;Pennington, C.J.;Scott, X.;Handsley, M.M.;Warn, A.;Gavrilovic, J.;Honert, K.;Krüger, A.;Span, P.N.;Sweep, F.C.;Edwards, D.R.
Distinct Functions of Natureal ADAM-15 Cytoplasmic Domain Variants in Human Mammary Carcinoma
Cancer Res.
2008
6
3
383-394

Matl, F.D.;Obermeier, A.;Repmann, S.;Friess, W.;Stemberger, A.;Kuehn, K.D.
New anti-infective coatings of medical implants based on lipid-like drug carriers.
Antimicrob Agents Chemother
2008

Haas, S.;Spyropoulos, A.C.
Primary Prevention of Venous Thromboembolism in Long-Term Care: Identifying and Managing the Risk
Clinical and Applied Thrombosis/Hemostasis
2008
14
2
149-158

Gast, D.;Riedle, S.;Issa, Y.;Pfeifer, M.;Beckhove, P.;Sanderson, M.P.;Arlt, M.;Moldenhauer, G.;Fogel, M.;Krüger, A.;Altevogt, P.
The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies
Oncogene
2008
27
1281-1289

Gerg, M.;Kopitz, C.;Schaten, S.;Tschukes, A.;Kahlert, C.;Stangl, M.;Hann von Weyhern, C.W.;Brucher, B.;Edwards, D.R.;Brand, K.;Krüger, A.
Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases
Mol Cancer Res.
2008
6
341-351

Vasiljeva, O.;Korovin, M.;Gajda, M.;Brodoefel, H.;Bojic, L.;Krüger, A.;Schurigt, U.;Sevenich, L.;Turk, B.;Peters, C.;Reinheckel, T.
Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
Oncogene
2008

Vogt, S.;Übelacker, P.;Geis, C.;Wagner, B.;Wexel, G.;Tischer, T.;Krüger, A.;Plank, C.;Anton, M.;Martinek, V.;Imhoff, A.B.;Gansbacher, B.
Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector
Science Direct - Biomaterials
2008
29
1242-1249

Mueck, W;Eriksson, BI;Bauer, KA;Borris, L;Dahl, OE;Fisher, WD;Gent, M;Haas, S;Huisman, MV;Kakkar, AK;Kälebo, B;Kwong, LM;Misselwitz, F;Turpie, AG
Population pharmacokinetics and pharmacodynamics of rivaroxaban - an oral, direct xa inhibitor - in patients undergoing major orthopaedic surgery
Clin Pharmacokinet
2008
47
3
203-216

Haas, S.
New oral Xa and IIa inhibitors: updates on clinical trial results
J Thromb Thrombolysis
2008
52-60